Asia-Pacific Animal Health Market

Asia-Pacific Animal Health Market by product (Parasiticides (Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive( Vitamin, Amino Acids, Antioxidant), Growth Promoter) Animal (Livestock, Companion), End-user (Hospitals) - Forecast to 2025

Report Code: PH 4669 Nov, 2020, by marketsandmarkets.com

[253 Pages Report] The APAC animal health market is projected to reach a value of USD 22.1 billion by 2025 from USD 15.6 billion in 2020,  at a CAGR of 7.2% during the forecast period. Factors such as the rapid rise in livestock population, increasing awareness about animal health, and rising frequency of animal disease outbreaks are expected to drive the growth of the APAC animal health market. However, restrictions on the use of parasiticides in food-producing animals, shift toward vegetarian diets, and the rising cost of storage of animal vaccines are expected to restrain the growth of this market.

Asia-Pacific Animal Health Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the APAC animal health Market

Coronavirus has spread across 215 countries and territories and affected more than 4.4 million people, with close to 300 thousand deaths. The pandemic has had considerable social and economic ramifications across a variety of industries and sectors. As of 28 October 2020, there have been 44,235,263 reported cases of COVID-19 (Source: Worldometer) from Africa, Asia Pacific, the Americas, Europe, and Oceania. The virus has resulted in 1,171,288 deaths. The true number of infected people would be much higher than the official total, as a large number of cases are asymptomatic and do not undergo testing.It could be assumed that there is a drastic change in the size of the APAC animal health market. The outbreak of COVID-19 originated from a meat market in Wuhan (China), which has negatively affected the consumption of food products derived from animal sources. In the realistic scenario, it could be assumed that there will be a partial effect of COVID-19 on the APAC animal health market. In this scenario, the major end-user segment for APAC animal health, namely, veterinary hospitals & clinics, animal farms, and homecare settings, are expected to be moderately impacted. This could be attributed to the scarcity of trade and transport restrictions, which are expected to recover gradually in Q4 of 2020 as trade relations in most countries achieve near-normalcy.

APAC animal health Market Dynamics

Drivers:  Rising demand of animal-derived food products

According to FAO, South Asia is one of the major regions for dairy production and accounted for 20–25% of the global milk production in 2019. In this region, India was the largest producer and consumer of milk, followed by China and Pakistan. In 2020, the consumption of meat in India was found to be over 3.9 million metric tons; by 2030, this is expected to increase to 145.7 million metric tons.

China accounted for the largest share of total pork, beef, and poultry meat consumption in the Asia Pacific region in 2019. The overall consumption of animal-derived food products is projected to increase by 2030.

Restraints: Shift towards vegetarian diet

There is a significant rise in the prevalence of obesity and other chronic disorders. Therefore, several people are shifting toward a vegetarian diet from a predominantly non-vegetarian diet. The prevalence of obesity has increased more than twofold since 1980. According to a journal published by Development Asia in 2018, two of five adults in the Asia Pacific region are found to be overweight or obese, and it is considered to be home to the largest absolute number of obese people, about 1 billion.

The prevalence of obesity in Asia Pacific ranges from less than 5% in India to 60% in Australia. Although the prevalence in China is a third of that in Australia, the increase in prevalence in China over the last 20 years was 400% compared to 20% in Australia.

Opportunities: Lucrative growth opportunities in India an China

Over the last few years, companion animal ownership has experienced steady growth, especially in emerging markets such as China and India. Rapid urbanization and growing disposable incomes are some of the key factors driving pet ownership in these countries. Many pet owners in these countries are now willing to spend more on pet care, specifically healthcare services.

These countries have robust livestock markets. According to a Dairy Tech India article, India is emerging as the world's second-largest poultry market, with an annual growth of more than 14%. India is the world's largest milk producer. According to the US Meat Export Federation, China ranks first in the world for pork consumption. The consumption of pork increased from 28.3 kg per person in 2012 to 34.2 kg per person in 2019.

Challenges: Growing resistance to parasites and antibodies

The prolonged use of specific parasiticides and antibiotics generates parasite resistance, which is a burning issue in the animal health market. Several farmers and pet owners tend to decrease the dosage of parasiticides or change the parasiticides used to combat resistance. However, this may prove detrimental in the long run and result in the development of multi-drug resistant parasite species.

The vaccines will have the highest growth rate, by product type, during the forecast period

Based on product, the APAC animal health market is segmented into parasiticides, antimicrobials and antibiotics, vaccines, feed additives/nutritional products, growth promoters, and other pharmaceuticals. Vaccines is expected to have the highest growth rate during the forecast period due to growing prevalence of animal-related diseases in Asian countries.

The food-producing animals had the largest share, by animal, in 2019.

Based on animal, the APAC animal health market is categorized into food-producing animals and companion animals. In 2019, food-producing animals accounted for large share of the APAC animal health market. The larger share of this segment is due to the increasing livestock population and rising demand for animal-derived food products.

Animal Farms are the largest end-user segment of the APAC animal health market.

Based on end-user, the market has been classified into veterinary hospitals & clinics, animal farms, and homecare. In 2019, the animal farms segment accounted for the largest market share of the APAC animal health market. This is because of the large population of livestock in emerging Asia Pacific countries, growing demand for animal-derived food products, and rising incidences of zoonotic diseases.

China market to witness the highest growth during the forecast period

The APAC animal health market is divided into five countries—China, Japan, India, Australia, and RoAPAC   These are analyzed further at the country levels. The Asia Pacific market is driven primarily by the increasing disposable income, growing awareness about animal health, rising demand of animal derived food products, and growing adoption of companion animals.

Asia-Pacific Animal Health Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The market is dominated by a few globally established players such as Zoetis (US), Boehringer Ingelheim (Germany), Elanco  (US), Merck & Co. (US), and Dechra (UK).

Report Metric

Details

Market size available for years

2018-2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Billion)

Segments covered

By Products, By Animal, By End-user

Geographies covered

Asia Pacific

Companies covered

The major market players include Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A (France), Ceva Sante Animale (France), Dechra Pharmaceuticals Plc. (UK), Kyoritsu Seiyako (Japan), Tianjin Ringpu (China), China Animal Husbandry (China), and Jinyu Bio-Technology (China).

The study categorizes the contact lenses market based on product, animal and end-user at the country levels.

By Products Type

  • By Parasiticides
    • Ectoparasiticides
      • Pour ons & Spot ons
      • Sprays
      • Dips
      • Ear-Tags
      • Collars
      • Oral Tablets
      • Other Ectoparasiticides
    • Endoparasiticides
      • Oral Liquids
      • Oral Solids
      • Injectables
      • Feed Additives
      • Other Endoparasiticides
    • Endectocides
  • Antimicrobials & Antibiotics
    • Tetracyclines
    • Penicillins
    • Sulfonamides
    • Macrolides
    • Others
  • Vaccines
    • Live Attenuated Vaccines
    • Inactivated Vaccines
    • Toxoid Vaccines
    • Other Vaccines
  • Feed Additives/Nutritional Products
    • Amino Acids
    • Binders
    • Vitamins
    • Minerals
    • Feed Acidifiers
    • Antioxidants
    • Other Feed Additives
  • Growth Promoter
    • Acidifiers
    • Hormonal Growth promoters
    • Prebiotics & Probiotics
    • Feed Enzymes
    • Phytogenics
    • Other Growth Promoters
  • Other Pharmaceuticals

By Animal Type

  • Food Producing Animals
    • Cattle
    • Pigs
    • Poultry
    • Sheep & Goats
    • Other Food Producing Animals
  • Companion  Animals
    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

By End-User

  • Veterinary Hospitals & Clinics
  • Animal Farms
  • Homecare

Recent Developments

  • In July 2020, Boehringer Ingelheim launched an external innovation hub in China.
  • In July 2020, Merck acquired the US rights from Virbac for the SENTINEL brand of combination parasiticides used to protect dogs against fleas and common intestinal parasites.
  • In July 2020, Zoetis announced a collaboration with Trianni for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments
  • In April 2020, Elanco collaborated with VetNow to provide relief to veterinarians by expanding its products and service access through the telemedicine platform.
  • In July 2017, Zoetis completed the acquisition of Nexvet, a biologic therapeutics company.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION & SCOPE
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKETS COVERED
        FIGURE 1 APAC ANIMAL HEALTH MARKET
           1.3.1 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 STAKEHOLDERS
    1.6 LIMITATIONS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 32)
    2.1 RESEARCH APPROACH
        FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                 FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                            FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.2 MARKET SIZE ESTIMATION
        FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
        FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
        FIGURE 7 COUNTRY-LEVEL ANALYSIS OF THE APAC ANIMAL HEALTH MARKET
        FIGURE 8 APPROACH 4: TOP-DOWN APPROACH
        FIGURE 9 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
        FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE APAC ANIMAL HEALTH MARKET (2020-2025)
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION
        FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ASSUMPTIONS
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 44)
  FIGURE 12 APAC ANIMAL HEALTH MARKET, BY PRODUCT TYPE,  2020 VS. 2025 (USD MILLION)
  FIGURE 13 APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2020 VS. 2025 (USD MILLION)
  FIGURE 14 APAC ANIMAL HEALTH MARKET, BY END-USER, 2020 VS. 2025 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 APAC ANIMAL HEALTH MARKET OVERVIEW
        FIGURE 15 EMERGING COUNTRIES TO OFFER GROWTH OPPORTUNITIES FOR MARKET PLAYERS
    4.2 ASIA PACIFIC: ANIMAL HEALTH MARKET, BY PRODUCT TYPE AND END-USER (2019)
        FIGURE 16 ANIMAL FARMS SEGMENT & FEED ADDITIVES ACCOUNTED FOR THE LARGEST MARKET SHARES IN 2019

5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 17 APAC ANIMAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising demand for animal-derived food products
                            FIGURE 18 COUNTRY-LEVEL CONSUMPTION OF ANIMAL DERIVED FOOD PRODUCTS (2020-2030), THOUSAND METRIC TONS
                            FIGURE 19 COUNTRY-LEVEL PRODUCTION OF ANIMAL DERIVED FOOD PRODUCTS  (2020-2030), THOUSAND METRIC TONS
                            FIGURE 20 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD IN 2018
                    5.2.1.2 Increasing livestock population and growing awareness about animal health
                            TABLE 1 APAC LIVESTOCK POPULATION, IN MILLION, 2014-2018
                             FIGURE 21 CATTLE POPULATION IN ASIA PACIFIC COUNTRIES, 2018 (IN MILLION)
                    5.2.1.3 Growing frequency of animal disease outbreaks
                            TABLE 2 ANIMAL DISEASE OUTBREAK IN ASIA PACIFIC COUNTRIES (2009-2019)
           5.2.2 RESTRAINTS
                    5.2.2.1 Restrictions on use of parasiticides in food-producing animals
                    5.2.2.2 Shift toward vegetarian diet
                    5.2.2.3 Rising vaccine storage cost
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Lucrative growth opportunities in India and China
                    5.2.3.2 Growth in companion animal ownership and rising adoption of pet health insurance
           5.2.4 CHALLENGES
                    5.2.4.1 Growing resistance to parasiticides and antibiotics
                            TABLE 3 PARASITICIDES AND RESISTANT PARASITES
                    5.2.4.2 Diversity of parasite species
                    5.2.4.3 Inadequate surveillance and reporting systems of vaccines
                    5.2.4.4 High costs of feed additive leading to adoption of conventional feeding systems
           5.2.5 INDUSTRY TRENDS
                    5.2.5.1 Innovations in animal healthcare products
                            TABLE 4 INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS
                    5.2.5.2 Consolidation in animal health industry
                            TABLE 5 SOME MAJOR ACQUISITIONS IN ANIMAL HEALTH INDUSTRY (2017-2019)
    5.3 COVID-19 HEALTH ASSESSMENT
    5.4 COVID-19 ECONOMIC ASSESSMENT
    5.5 ASSESSMENT OF COVID-19 IMPACT ON ECONOMIC SCENARIO
        FIGURE 22 CRITERIA IMPACTING THE GLOBAL ECONOMY
        FIGURE 23 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY
    5.6 ASSESSMENT OF IMPACT OF COVID-19 ON ECONOMIC SCENARIO PERTAINING TO APAC ANIMAL HEALTH MARKET
    5.7 VALUE CHAIN ANALYSIS
        FIGURE 24 APAC ANIMAL HEALTH MARKET: VALUE CHAIN ANALYSIS
    5.8 ECOSYSTEM MARKET MAP
        FIGURE 25 APAC ANIMAL HEALTH MARKET: ECOSYSTEM MARKET MAP

6 APAC ANIMAL HEALTH MARKET, BY PRODUCT (Page No. - 66)
    6.1 INTRODUCTION
        TABLE 6 APAC ANIMAL HEALTH MARKET, BY PRODUCT TYPE 2018–2025 (USD MILLION)
    6.2 GROWTH PROMOTERS
        TABLE 7 APAC ANIMAL GROWTH PROMOTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 8 APAC ANIMAL GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.1 PROBIOTICS & PREBIOTICS
                    6.2.1.1 Restrictions on the use of antibiotics have promoted the growth of probiotics & prebiotics
                            TABLE 9 APAC PROBIOTICS & PREBIOTICS GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.2 ACIDIFIERS
                    6.2.2.1 Regulations on the use of antibiotics and wide applications in different food-producing animals are driving the use of acidifiers
                            TABLE 10 APAC ACIDIFIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.3 PHYTOGENICS
                    6.2.3.1 Natural performance enhancement and antioxidative and disease defense properties support the use of phytogenics
                            TABLE 11 APAC PHYTOGENICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.4 FEED ENZYME GROWTH PROMOTERS
                    6.2.4.1 Feed enzymes segment is expected to benefit significantly due to the ban on antibiotics and hormones
                            TABLE 12 APAC FEED ENZYME GROWTH PROMOTERS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
           6.2.5 HORMONAL GROWTH PROMOTERS
                    6.2.5.1 Routine use of hormonal growth promoters in east Asian countries contribute to their market growth
                            TABLE 13 APAC HORMONAL GROWTH PROMOTERS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
           6.2.6 OTHER GROWTH PROMOTERS
                 TABLE 14 APAC OTHER GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.3 FEED ADDITIVES/NUTRITIONAL PRODUCTS
        TABLE 15 APAC ANIMAL FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY TYPE,  2018–2025 (USD MILLION)
        TABLE 16 APAC ANIMAL FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
           6.3.1 AMINO ACIDS
                    6.3.1.1 High nutritional benefits and low cost drive the growth  of amino acids
                            TABLE 17 APAC AMINO ACIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.2 BINDERS
                    6.3.2.1 Binders increase productivity of animal derived products, leading to their market growth
                            TABLE 18 APAC BINDERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.3 VITAMINS
                    6.3.3.1 Rising importance of vitamins as a key constituent for metabolic functions in livestock is projected to drive the market
                            TABLE 19 APAC VITAMINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.4 MINERALS
                    6.3.4.1 Multiple functions of minerals in animals driving growth
                            TABLE 20 APAC MINERALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.5 FEED ACIDIFIERS
                    6.3.5.1 Improvement in economic performance of livestock due to feed acidifiers expected to lead to market growth
                            TABLE 21 APAC FEED ACIDIFIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.6 ANTIOXIDANTS
                    6.3.6.1 Reduced wastage and improved nutrition promote the growth of antioxidants
                            TABLE 22 APAC ANTIOXIDANTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.7 OTHER FEED ADDITIVES/NUTRITIONAL PRODUCTS
                 TABLE 23 APAC OTHER FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
    6.4 VACCINES
        TABLE 24 APAC ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 25 APAC ANIMAL VACCINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.4.1 LIVE ATTENUATED VACCINE
                    6.4.1.1 Live attenuated vaccine accounted for the largest share of the APAC animal vaccine market in 2019
                            TABLE 26 APAC LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.4.2 INACTIVATED VACCINES
                    6.4.2.1 High cost and short-lasting immunity hinder the growth of inactivated vaccines
                            TABLE 27 APAC INACTIVATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.4.3 TOXOID VACCINES
                    6.4.3.1 Safety and stability of toxoid vaccines to lead to market growth
                            TABLE 28 APAC TOXOID VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.4.4 RECOMBINANT VACCINES
                    6.4.4.1 Advantages associated with recombinant vaccines driving their demand
                            TABLE 29 APAC RECOMBINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.4.5 OTHER VACCINES
                 TABLE 30 APAC OTHER VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.5 PARASITICIDES
        TABLE 31 APAC ANIMAL PARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 32 APAC ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.5.1 ECTOPARASITICIDES
                 TABLE 33 APAC ANIMAL ECTOPARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 34 APAC ANIMAL ECTOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.5.1.1 Pour-ons & spot-ons
                               6.5.1.1.1 Ease of application support the demand for pour-ons & spot-ons
                                         TABLE 35 APAC ANIMAL ECTOPARASITICIDE POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.5.1.2 Oral tablets
                               6.5.1.2.1 High medication compliance and ease of administration are key growth drivers in this market
                                         TABLE 36 APAC ANIMAL ORAL ECTOPARASITICIDE TABLETS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.1.3 Sprays
                               6.5.1.3.1 Low price and convenient handling drive market growth
                                         TABLE 37 APAC ANIMAL ECTOPARASITICIDE SPRAYS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.1.4 Dips
                               6.5.1.4.1 The high popularity of dips ensures sustained end user demand
                                         TABLE 38 APAC ANIMAL ECTOPARASITICIDE DIPS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.1.5 Ear tags
                               6.5.1.5.1 Ear tags are highly effective in controlling flies around cattle
                                         TABLE 39 APAC ANIMAL ECTOPARASITICIDE EAR TAGS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.1.6 Collars
                               6.5.1.6.1 Increasing prevalence of infections in companion animals drive the growth of collars
                                         TABLE 40 APAC ANIMAL ECTOPARASITICIDE COLLARS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.1.7 Other ectoparasiticides
                            TABLE 41 APAC ANIMAL OTHER ECTOPARASITICIDES MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
           6.5.2 ENDOPARASITICIDES
                 TABLE 42 APAC ANIMAL ENDOPARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 43 APAC ANIMAL ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.5.2.1 Oral liquids
                               6.5.2.1.1 Increasing demand for meat and milk drives the growth of the oral liquids market
                                         TABLE 44 APAC ANIMAL ORAL LIQUID ENDOPARASITICIDES MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.2.2 Oral solids
                               6.5.2.2.1 The emergence of internal parasitic infections in dogs is expected to drive the growth of the oral solids market
                                         TABLE 45 APAC ANIMAL ORAL SOLID ENDOPARASITICIDES MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.2.3 Injectables
                               6.5.2.3.1 Injectables offer rapid results, which has supported their use
                                         TABLE 46 APAC ANIMAL INJECTABLE ENDOPARASITICIDES MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    6.5.2.4 Feed additives
                               6.5.2.4.1 Feed additives can be administered to large numbers of animals at once
                                         TABLE 47 APAC ANIMAL FEED ADDITIVES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.5.2.5 Other endoparasiticides
                            TABLE 48 APAC ANIMAL OTHER ENDOPARASITICIDES MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
           6.5.3 ENDECTOCIDES
                    6.5.3.1 Multiple applications against several parasites drive the growth of endectocides
                            TABLE 49 PLAYERS IN THE ENDECTOCIDES MARKET
                            TABLE 50 APAC ANIMAL ENDECTOCIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.6 ANTIMICROBIALS & ANTIBIOTICS
        TABLE 51 APAC ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET, BY TYPE,  2018–2025 (USD MILLION)
        TABLE 52 APAC ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
           6.6.1 TETRACYCLINES
                    6.6.1.1 Reduced cost is a key factor driving higher use of tetracyclines across emerging Asian countries
                            TABLE 53 APAC TETRACYCLINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.6.2 PENICILLINS
                    6.6.2.1 Rising incidences of zoonotic diseases in livestock animals expected to drive growth of penicillins
                            TABLE 54 APAC PENICILLINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.6.3 SULFONAMIDES
                    6.6.3.1 Reduced cost and multiple applications in livestock infections drive demand for sulfonamides in rural Asian regions
                            TABLE 55 APAC SULFONAMIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.6.4 MACROLIDES
                    6.6.4.1 Increasing production of cattle derived food products expected to drive the growth of macrolides
                            TABLE 56 APAC MACROLIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.6.5 AMINOGLYCOSIDES
                    6.6.5.1 Rising prevalence of animal-related diseases in rural regions of Asia Pacific expected to drive the demand for aminoglycosides
                            TABLE 57 APAC AMINOGLYCOSIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.6.6 CEPHALOSPORINS
                    6.6.6.1 Increasing adoption of pets in Asian countries expected to drive the growth of cephalosporins
                            TABLE 58 APAC CEPHALOSPORINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.6.7 OTHER ANTIBIOTICS & ANTIMICROBIALS
                 TABLE 59 APAC OTHER ANTIBIOTICS & ANTIMICROBIALS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
    6.7 OTHER PHARMACEUTICALS
        TABLE 60 APAC OTHER PHARMACEUTICALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

7 APAC ANIMAL HEALTH MARKET, BY ANIMAL (Page No. - 105)
    7.1 INTRODUCTION
        TABLE 61 APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
    7.2 FOOD PRODUCING ANIMALS
        TABLE 62 PER CAPITA CONSUMPTION OF MEAT IN MAJOR APAC COUNTRIES, (IN KG), 2019
        TABLE 63 APAC ANIMAL HEALTH MARKET FOR FOOD PRODUCING ANIMALS, BY TYPE,  2018–2025 (USD MILLION)
        TABLE 64 FOOD-PRODUCING ANIMAL, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.1 CATTLE
                    7.2.1.1 Increasing beef consumption and milk production to drive the segment
                            TABLE 65 APAC ANIMAL HEALTH MARKET FOR CATTLE, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.2 PIGS
                    7.2.2.1 Growing incidences of zoonotic diseases will require better health maintenance of pigs
                            TABLE 66 APAC ANIMAL HEALTH MARKET FOR PIGS, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.3 POULTRY
                    7.2.3.1 Growing egg consumption in emerging countries to drive the segment
                            FIGURE 26 LEADING EGG PRODUCING COUNTRIES IN ASIA PACIFIC (NUMBER OF EGGS, IN BILLION), 2018
                            TABLE 67 APAC ANIMAL HEALTH MARKET FOR POULTRY, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.4 SHEEP AND GOATS
                    7.2.4.1 Increasing population of sheep and goats is expected to drive the segment
                            TABLE 68 APAC ANIMAL HEALTH MARKET FOR SHEEP AND GOATS, BY COUNTRY,  2018–2025 (USD MILLION)
           7.2.5 OTHER FOOD-PRODUCING ANIMALS
                 FIGURE 27 CONSUMPTION OF FISH AND FISH PRODUCTS PER YEAR IN ASIAN COUNTRIES, PER CAPITA (IN KG)
                 TABLE 69 APAC ANIMAL HEALTH MARKET FOR OTHER FOOD PRODUCING ANIMALS, BY COUNTRY, 2018–2025 (USD MILLION)
    7.3 COMPANION ANIMALS
        TABLE 70 APAC COMPANION ANIMAL MARKET, BY TYPE 2018–2025 (USD MILLION)
        TABLE 71 APAC COMPANION ANIMAL MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.1 DOGS
                    7.3.1.1 Growing adoption of dogs to drive the segment
                            FIGURE 28 GROWING POPULATION OF PET DOGS IN INDIA (MILLION)
                            TABLE 72 APAC ANIMAL HEALTH MARKET FOR DOGS, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.2 CATS
                    7.3.2.1 Increasing adoption of cats in South Asia to drive the segment
                 TABLE 73 APAC ANIMAL HEALTH MARKET FOR CATS, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.3 HORSES
                    7.3.3.1 Declining horse population demands adoption of health products
                 TABLE 74 APAC ANIMAL HEALTH MARKET FOR HORSES, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.4 OTHER COMPANION ANIMALS
                 TABLE 75 APAC ANIMAL HEALTH MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2018–2025 (USD MILLION)

8 APAC ANIMAL HEALTH MARKET, BY END-USER (Page No. - 118)
    8.1 INTRODUCTION
        TABLE 76 APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
    8.2 ANIMAL FARMS
           8.2.1 GROWING LIVESTOCK POPULATION IN DEVELOPING COUNTRIES TO DRIVE THE SEGMENT
                 TABLE 77 GROWTH IN PRODUCTION OF MEAT AND MILK IN ASIA, 2015–2030, BY REGION
                 TABLE 78 GROWTH IN CONSUMPTION OF MEAT AND MILK IN ASIA, 2015–2030, BY REGION
                 TABLE 79 GROWTH IN PRODUCTION OF LIVESTOCK COMMODITIES IN ASIA, THOUSAND TONNES,2017–2030
                 TABLE 80 APAC ANIMAL HEALTH MARKET FOR ANIMAL FARMS, BY COUNTRY,  2018–2025 (USD MILLION)
    8.3 VETERINARY HOSPITALS & CLINICS
           8.3.1 GROWING ANIMAL HEALTH AWARENESS WILL DRIVE THE SEGMENT
                 FIGURE 29 ASIA PACIFIC TO SHOW HIGHEST GROWTH RATE IN PET INDUSTRY BY 2022
                 TABLE 81 APAC ANIMAL HEALTH MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
    8.4 HOMECARE
           8.4.1 RISING PET OWNERSHIP RATES TO DRIVE THE SEGMENT
                 TABLE 82 APAC ANIMAL HEALTH MARKET FOR HOMECARE, BY COUNTRY,  2018–2025 (USD MILLION)

9 APAC ANIMAL HEALTH MARKET, BY COUNTRY (Page No. - 124)
    9.1 INTRODUCTION
        FIGURE 30 APAC ANIMAL HEALTH MARKET: SNAPSHOT
           9.1.1 CHINA
                    9.1.1.1 Increasing pork consumption and growing pet adoption to drive the market
                            FIGURE 31 CHINA: PROJECTED COMPANION ANIMAL POPULATION, 2018-2025 (MILLION)
                            FIGURE 32 CHINA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION,  2018–2025 (MILLION)
                            FIGURE 33 INCREASING CONSUMPTION OF PORK PRODUCTS IN CHINA, PER CAPITA (IN KILOGRAMS) (2011–2020)
                            FIGURE 34 GROWING CATTLE PRODUCTION IN CHINA, PER THOUSAND HEAD, 2009–2020
                            TABLE 83 CHINA: ANIMAL FEED ADDITIVE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 84 CHINA: ANIMAL GROWTH PROMOTER PRODUCT MARKET, BY TYPE,  2018–2025 (USD MILLION)
                            TABLE 85 CHINA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 86 CHINA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 87 CHINA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 88 CHINA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 89 CHINA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE,  2018–2025 (USD MILLION)
                            TABLE 90 CHINA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
                            TABLE 91 CHINA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL,  2018–2025 (USD MILLION)
                            TABLE 92 CHINA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL,  2018–2025 (USD MILLION)
                            TABLE 93 CHINA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
           9.1.2 JAPAN
                    9.1.2.1 Rising awareness about zoonotic diseases is expected to drive the market
                            FIGURE 35 JAPAN: PROJECTED COMPANION ANIMAL POPULATION, 2018-2025 (MILLION)
                            FIGURE 36 JAPAN: PROJECTED FOOD-PRODUCING ANIMAL POPULATION,  2018–2025 (MILLION)
                            TABLE 94 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS)
                            TABLE 95 JAPAN: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE,  2018–2025 (USD MILLION)
                            TABLE 96 JAPAN: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 97 JAPAN: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 98 JAPAN: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 99 JAPAN: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 100 JAPAN: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 101 JAPAN: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 102 JAPAN: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
                            TABLE 103 JAPAN: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL,  2018–2025 (USD MILLION)
                            TABLE 104 JAPAN: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL,  2018–2025 (USD MILLION)
                            TABLE 105 JAPAN: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
           9.1.3 INDIA
                    9.1.3.1 Large livestock population and increasing production and export capacities to drive the market
                            FIGURE 37 INDIA: PROJECTED COMPANION ANIMAL POPULATION, 2018–2025 (MILLION)
                            FIGURE 38 INDIA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION,  2018–2025, (MILLION)
                            FIGURE 39 INCREASING LIVESTOCK AND POULTRY POPULATION IN INDIA,  2003–2019 (MILLION)
                            TABLE 106 INDIA: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE,  2018–2025 (USD MILLION)
                            TABLE 107 INDIA: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 108 INDIA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 109 INDIA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 110 INDIA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 111 INDIA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 112 INDIA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE,  2018–2025 (USD MILLION)
                            TABLE 113 INDIA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
                            TABLE 114 INDIA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL,  2018–2025 (USD MILLION)
                            TABLE 115 INDIA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL,  2018–2025 (USD MILLION)
                            TABLE 116 INDIA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
           9.1.4 AUSTRALIA
                    9.1.4.1 Increasing pet population is expected to drive the market
                            FIGURE 40 AUSTRALIA: PROJECTED COMPANION ANIMAL POPULATION,  2018–2025 (MILLION)
                            FIGURE 41 AUSTRALIA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION,  2018–2025 (MILLION)
                            TABLE 117 AUSTRALIA: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE,  2018–2025 (USD MILLION)
                            TABLE 118 AUSTRALIA: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 119 AUSTRALIA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 120 AUSTRALIA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 121 AUSTRALIA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 122 AUSTRALIA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 123 AUSTRALIA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE,  2018–2025 (USD MILLION)
                            TABLE 124 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018-2025(USD MILLION)
                            TABLE 125 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018-2025 (USD MILLION)
                            TABLE 126 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL,  2018-2025(USD MILLION)
                            TABLE 127 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
           9.1.5 REST OF ASIA PACIFIC
                 TABLE 128 ROAPAC: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE,  2018–2025 (USD MILLION)
                 TABLE 129 ROAPAC: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 130 ROAPAC: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 131 ROAPAC: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 132 ROAPAC: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 133 ROAPAC: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 134 ROAPAC: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE,  2018–2025 (USD MILLION)
                 TABLE 135 ROAPAC: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018-2025(USD MILLION)
                 TABLE 136 ROAPAC: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL,  2018-2025(USD MILLION)
                 TABLE 137 ROAPAC: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL,  2018-2025(USD MILLION)
                 TABLE 138 ROAPAC: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 156)
     10.1 INTRODUCTION
          FIGURE 42 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND 2020
     10.2 MARKET EVALUATION FRAMEWORK
          FIGURE 43 MARKET EVALUATION FRAMEWORK: MARKET CONSOLIDATION THROUGH PARTNERSHIPS, COLLABORATIONS, ACQUISITIONS, AND AGREEMENTS IN 2019
     10.3 PRODUCT PORTFOLIO MATRIX
             10.3.1 PARASITICIDES
             10.3.2 VACCINES
             10.3.3 ANTIBIOTICS & ANTIMICROBIALS
             10.3.4 FEED ADDITIVES & NUTRITIONAL PRODUCTS
             10.3.5 GROWTH PROMOTERS
     10.4 APAC ANIMAL HEALTH MARKET: GEOGRAPHICAL ASSESSMENT
          FIGURE 44 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE APAC ANIMAL HEALTH MARKET (2019)
     10.5 APAC ANIMAL HEALTH MARKET: R&D EXPENDITURE
          FIGURE 45 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL HEALTH MARKET (2019)
     10.6 REVENUE ANALYSIS OF KEY MARKET PLAYERS
          FIGURE 46 REVENUE ANALYSIS: APAC ANIMAL HEALTH MARKET 2019
     10.7 VENDOR DIVE
             10.7.1 STARS
             10.7.2 EMERGING LEADERS
             10.7.3 PERVASIVE
             10.7.4 EMERGING COMPANIES
                    FIGURE 47 COMPETITIVE LEADERSHIP MAPPING: APAC ANIMAL HEALTH MARKET, 2019
     10.8 MARKET SHARE ANALYSIS
          FIGURE 48 ANIMAL HEALTH MARKET SHARE ANALYSIS,  BY KEY PLAYER, 2019
     10.9 COMPETITIVE SITUATIONS AND TRENDS
          FIGURE 49 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & APPROVALS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS PURSUED BY MARKET PLAYERS BETWEEN 2017 & 2020
             10.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS
                    TABLE 139 PRODUCT LAUNCHES AND ENHANCEMENTS (2017 – SEPTEMBER 2020)
             10.9.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
                    TABLE 140 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–SEPTEMBER 2020)
             10.9.3 MERGERS & ACQUISITIONS AND DIVESTITURES
                    TABLE 141 MERGERS & ACQUISITIONS, DIVESTITURES (2017–SEPTEMBER 2020)
             10.9.4 EXPANSIONS
                    TABLE 142 EXPANSIONS (2017–SEPTEMBER 2020)

11 STARTUP MATRIX (Page No. - 173)
     11.1 COMPETITIVE LEADERSHIP MAPPING (SMES/STARTUP)
             11.1.1 PROGRESSIVE COMPANIES
             11.1.2 STARTING BLOCKS
             11.1.3 RESPONSIVE COMPANIES
             11.1.4 DYNAMIC COMPANIES
                    FIGURE 50 EMERGING PLAYERS VENDOR DIVE: EVALUATION OVERVIEW

12 COMPANY PROFILES (Page No. - 175)
(Business Overview, Products Offered, Recent Developments, MnM View, Strategic Overview, Right To Win)*
     12.1 BOEHRINGER INGELHEIM
          FIGURE 51 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2019)
     12.2 ELANCO ANIMAL HEALTH
          FIGURE 52 ELANCO: COMPANY SNAPSHOT (2019)
     12.3 MERCK ANIMAL HEALTH
          FIGURE 53 MERCK: COMPANY SNAPSHOT (2019)
     12.4 ZOETIS INC.
          FIGURE 54 ZOETIS: COMPANY SNAPSHOT (2019)
     12.5 VIRBAC
          FIGURE 55 VIRBAC: COMPANY SNAPSHOT (2019)
     12.6 VETOQUINOL S.A.
          FIGURE 56 VETOQUINOL: COMPANY SNAPSHOT (2019)
     12.7 PHIBRO ANIMAL HEALTH
          FIGURE 57 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
     12.8 CEVA SANTΙ ANIMALE
     12.9 DECHRA PHARMACEUTICALS PLC.
          FIGURE 58 DECHRA: COMPANY SNAPSHOT (2019)
     12.10 KYORITSU SEIYAKO
     12.11 TIANJIN RINGPU
     12.12 CHINA ANIMAL HUSBANDRY
     12.13 JINYU BIO-TECHNOLOGY
     12.14 ZYDUS ANIMAL HEALTH
           FIGURE 59 ZYDUS: COMPANY SNAPSHOT (2019)
     12.15 HIPRA
     12.16 ENDOVAC ANIMAL HEALTH
     12.17 BOVICURE PHARMA
     12.18 INDIAN IMMUNOLOGICALS LTD.
     12.19 ASHISH LIFE SCIENCE (ALS)
     12.20 LUTIM PHARMA

*Business Overview, Products Offered, Recent Developments, MnM View Strategic Overview, Right To Win might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 243)
     13.1 INSIGHTS OF INDUSTRY EXPERTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS

This study involved four major activities for estimating the current size of the APAC animal health market. Exhaustive secondary research was conducted to collect information on the market and its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, Parent Market, and top-down approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.

Secondary Research

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the APAC animal health market. Primary sources from the demand side include experts from hospitals and clinics and research and academic laboratories. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.

Asia-Pacific Animal Health Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the APAC animal health market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach to calculate the revenue of different players in the APAC animal health market

The size of the APAC animal health market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global APAC animal health market was derived.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the APAC animal health market based on product and animal type, and end user.
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies2 in the APAC animal health market
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, new product developments, geographic expansions, and research and development activities in the APAC animal health market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top companies

Geographic Analysis

  • Further breakdown of the RoAPAC market into South Korea, New Zealand, Singapore, and other countries.

Company Information

  • Detailed analysis and profiling of additional market players, up to five.
COVID-19

Get in-depth analysis of the COVID-19 impact on the Asia-Pacific Animal Health Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Asia-Pacific Animal Health Market

Request For Special Pricing
Report Code
PH 4669
Published ON
Nov, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Asia-Pacific Animal Health Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home